比较CT体积测量、锝99m半乳糖基血清白蛋白闪烁显像与钆塞酸增强MRI在术前患者中评估肝纤维化分期的价值
本回顾性研究纳入91例术前接受动态CT和99mTc-GSA闪烁显像的患者(其中76例接受EOB-MRI),比较CT体积测量、99mTc-GSA闪烁显像和EOB-MRI评估肝纤维化分期的效能。多因素分析显示,脾体积/体表面积、EOB-MRI肝胆期肝脾比值和透明质酸是严重肝纤维化(F3-4)的独立预测因子,三者联合的AUC为0.91,显著高于GSA指数(AUC=0.84)、脾体积/体表面积(AUC=0.83)或肝脾比值(AUC=0.75)单独应用。结论认为联合CT体积测量、EOB-MRI和透明质酸分析可提高严重肝纤维化的评估准确性。
要点
- 脾体积/体表面积(OR 1.01)、EOB-MRI肝胆期肝脾比值(OR 0.06)和透明质酸(OR 1.01)是严重肝纤维化(F3-4)的独立预测因子。
- 三者联合评估严重肝纤维化的AUC为0.91,高于GSA指数(0.84)、脾体积/体表面积(0.83)或肝脾比值(0.75)单独应用。
- CT体积测量和EOB-MRI可检测严重肝纤维化,后者可能与肝切除术后肝衰竭和并发症相关。
核心结论
- 联合CT体积测量、EOB-MRI和透明质酸分析较单独应用CT体积测量、EOB-MRI或99mTc-GSA闪烁显像能提高严重肝纤维化的评估准确性。
研究设计与样本
- 回顾性研究,纳入91例连续接受术前动态CT和99mTc-GSA闪烁显像的患者,其中76例接受EOB-MRI,65例测量透明质酸和4型胶原水平;采用逻辑回归和ROC分析。
诊断标准与关键数值
- 严重肝纤维化(F3-4)的多因素逻辑回归:脾体积/体表面积OR 1.01(95%CI 1.003-1.02,p=0.011),肝脾比值OR 0.06(95%CI 0.004-0.70,p=0.026),透明质酸OR 1.01(95%CI 1.001-1.02,p=0.024)。联合脾体积/体表面积、肝脾比值和透明质酸评估严重肝纤维化的AUC为0.91,显著大于GSA指数(AUC=0.84)、脾体积/体表面积(AUC=0.83)或肝脾比值(AUC=0.75)单独应用。
临床应用与阅片要点
- 联合分析CT体积测量的脾体积、钆塞酸增强MRI的肝脾比值和透明质酸可识别与肝切除术后肝衰竭及肝细胞癌复发高风险相关的严重肝纤维化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the efficacy of computed tomography volumetry (CTV), technetium99m galactosyl-serum-albumin (99mTc-GSA) scintigraphy, and gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic-acid-enhanced MRI (EOB-MRI) in estimating the liver fibrosis (LF) stage in patients undergoing liver resection.
METHODS: This retrospective study included 91 consecutive patients who had undergone preoperative dynamic CT and 99mTc-GSA scintigraphy. EOB-MRI was performed in 76 patients. CTV was used to measure the total liver volume (TLV), spleen volume (SV), normalised to the body surface area (BSA), and liver-to-spleen volume ratio (TLV/SV). 99mTc-GSA scintigraphy provided LHL15, HH15, and GSA indices. The liver-to-spleen ratio (LSR) was calculated in the hepatobiliary phase of EOB-MRI. Hyaluronic acid and type 4 collagen levels were measured in 65 patients. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify useful parameters for estimating the LF stage and laboratory data.
RESULTS: According to the multivariable logistic regression analysis, SV/BSA (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.003-1.02; p = 0.011), LSR (OR, 0.06; 95%CI, 0.004-0.70; p = 0.026), and hyaluronic acid (OR, 1.01; 95%CI, 1.001-1.02; p = 0.024) were independent variables for severe LF (F3-4). Combined SV/BSA, LSR, and hyaluronic acid correctly estimated severe LF, with an AUC of 0.91, which was significantly larger than the AUCs of the GSA index (AUC = 0.84), SV/BSA (AUC = 0.83), or LSR (AUC = 0.75) alone.
CONCLUSIONS: Combined CTV, EOB-MRI, and hyaluronic acid analyses improved the estimation accuracy of severe LF compared to CTV, EOB-MRI, or 99mTc-GSA scintigraphy individually.
CLINICAL RELEVANCE STATEMENT: The combined analysis of spleen volume on CT volumetry, liver-to-spleen ratio on gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic-acid-enhanced MRI, and hyaluronic acid can identify severe liver fibrosis associated with a high risk of liver failure after hepatectomy and recurrence in patients with hepatocellular carcinoma.
KEY POINTS: • Spleen volume of CT volumetry normalised to the body surface area, liver-to-spleen ratio of EOB-MRI, and hyaluronic acid were independent variables for liver fibrosis. • CT volumetry and EOB-MRI enable the detection of severe liver fibrosis, which may correlate with post-hepatectomy liver failure and complications. • Combined CT volumetry, gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic-acid-enhanced MRI (EOB-MRI), and hyaluronic acid analyses improved the estimation of severe liver fibrosis compared to technetium99m galactosyl-serum-albumin scintigraphy.
引用
- Nakazawa Y, Okada M, Hyodo T, et al. Comparison between CT volumetry, technetium99m galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients. Eur Radiol. 2023. PMID: 37673964. doi:10.1007/s00330-023-10219-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。